Determination of developmental stages of Cryptosporidium parvum in HCT-8 cell culture by differential interference contrast microscopy, Giemsa and haematoxylin-eosin staining methods
Bu çalışmada, interferans kontrast mikrsokopisi, Giemsa ve hematoksilin-eosin boyama yöntemlerinin, Cryptosporidium parvum’un hücre kültüründeki gelişme evrelerinin belirlenmesi konusundaki yetilerinin karşılaştırılması amaçlanmıştır. Elde edilen veriler, interferans kontrast mikroskopisi ve Giemsa boyama yönteminin söz konusu parazitin gelişme evrelerinin belirlenmesinde bazı önemli avantajlara sahip olduğunu, formalin ile tespit işlemini takiben uygulanan hematoksilin-eosin boyama tekniğinin ise parazitte meydana gelen bazı değişikliklerin kolayca belirlenmesini sağladığını göstermiştir. Taramalarda, interferans kontrast mikroskopisi ile meront ve mikrogametlerin kesin olarak ayırt edilebileceği, boyama yöntemleriyle ise sadece merontların belirlenebileceği anlaşılmıştır.
Cryptosporidium parvum’un HCT-8 Hücre Kültüründeki gelişme evrelerinin diferansiyel interferans kontrast mikroskopisi, Giemsa ve hematoksilin-eozin boyama yöntemleriyle belirlenmesi
This study aimed to compare the advantages of diff erential interference contrast microscopy, Giemsa and haematoxylin-eosin staining techniques for detecting, visualizing and distinguishing the developmental stages of Cryptosporidium parvum in cell culture. Data showed that interference contrast microscopy and Giemsa staining have certain advantages, whereas haematoxylin-eosin staining followed by formalin fi xation clearly reveals certain changes occurred in the parasite. In the investigations, it was revealed that direct microscopy is eff ective in accurate defi nition of meronts and microgamets, but staining methods can diff erentiate meronts only.
___
- 1. Rochelle PA, Fergusson DM, Handojo TJ, De Leon R, Stewart MH, Wolfe RL: An assay combining cell culture with reverse transcriptase PCR to detect and determine the infectivity of waterborne Cryptosporidium parvum. Appl Environ Microbiol, 63 (5): 2029-2037, 1997.
- 2. Joachim A, Eckert E, Petry F, Bialek R, Daugschies A: Comparison of viability assays for Cryptosporidium parvum oocysts after disinfection. Vet Parasitol, 111 (1): 47-57, 2002.
- 3. Najdrowski M, Joachim A, Daugschies A: An improved in vitro infection model for viability testing of Cryptosporidium parvum oocysts. Vet Parasitol, 150 (1-2): 150-154, 2007.
- 4. Hijjawi NS, Meloni BP, Morgan UM, Thompson RCA: Complete development and long-term maintenance of Cryptosporidium parvum human and cattle genotypes in cell culture. Int J Parasitol, 31 (10): 1048-2055, 2001.
- 5. Meloni BP, Thompson RCA: Simplified methods for obtaining purified oocysts from mice and for growing Cryptosporidium parvum in vitro. J Parasitol, 82 (5): 757-762, 1996.
- 6. Widmer G, Corey EA, Stein B, Griffi ths JK, Tzipori S: Host cell apoptosıs impairs Cryptosporidium parvum development in vitro. J parasitol, 86 (5): 922-928, 2000.
- 7. Lacharme L, Villar V, Rojo-Vazquez FA, Suarez S: Complete development of Cryptosporidium parvum in rabbit chondrocytes (VELI cells). Microbes Infect, 6 (6): 566-571, 2004.
- 8. McDonald V, Stables R, Warhurst DC, Barer MR, Blewett DA, Chapman HD, Connally GM, Chiodini PL, McAdam KPWJ: In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs. Antimicrob Ag Chemother, 34, 1498-1500, 1990.
- 9. Choi MH, Hong ST, Park WY, Yu JR: In vitro culture of Cryptosporidium muris in human stomach adenocarcinoma cell line. Korean J Parasitol, 42 (1): 27-34, 2004.
- 10. Slifko TR, Friedman DE, Rose JB, Jakubowski W: An in vitro method for detecting infectious Cryptosporidium oocysts with cell culture. Appl Env Microbiol, 63 (9): 3669-3675, 1997.
- 11. Mele R, Gomez Morales MAG, Tosini F, Pozio E: Cryptosporidium parvum at diff erent developmental stages modulates host cell apoptosis in vitro. Infect Immunol, 72 (10): 6061-6067, 2004.
- 12. Villacorta I, De Graff D, Charlier G, Peeters JE: Complete development of Cryptosporidium parvum in MDBK cells. FEMS Microbiol Lett, 142, 129-132, 1996.
- 13. Woodmansee DB, Pohlenz JFL: Development of Cryptosporidium sp. in a human rectal tumor cell line. In, Proc 4th Int Symp Neonatal Diarrhea, Veterinary Infectious Disease Organization, University of Saskatchewan, Saskatoon, Canada. 1983, 306-319, 1983.
- 14. Yu JR, Choi SD, Kim YW: In vitro infection of Cryptosporidium parvum to four diff erent cell lines. Korean J Parasitol, 38 (2): 59-64, 2000.
- 15. Flanigan TP, Aji T, Soave R, Aikawa M, Kaetzel C: Asexual development of Cryptosporidium parvum within a diff erential human enterocyte cell line. Infect Immun, 59 (1): 234-239, 1991.
- 16. Lawton P, Naciri M, Mancassola R, Petavy A: In vitro cultivation of Cryptosporidium parvum in the non-adherent human monocytic THP-1 cell line. J Euk Microbiol, 44 (6): 66, 1997.
- 17. Current WL, Haynes TB: Complete development of Cryptosporidium in cell culture. Science, 224 (4649): 603-605, 1984.
- 18. Current WL, Long PL: Development of human and calf Cryptosporidium in chicken embryos. J Infect Dis, 148 (6): 1108-1113, 1983.
- 19. Upton SJ, Tilley M, Brillhart DB: Comparative development of Cryptosporidium parvum (Apicomplexa) in 11 continuous host cell lines. FEMS Microbiol Lett, 118 (3): 233-236, 1994.
- 20. Upton SJ, Tilley M, Nesterenko MV, Brillhart DB: A simple and reliable method of producing in vitro infections of Cryptosporidium parvum (Apicomplexa). FEMS Microbiol Lett, 118 (1-2): 45-49, 1994.
- 21. Ojcius DM, Perfettini JL, Bonnin A, Laurent F: Caspasedependent apoptosis during infection with Cryptosporidium parvum. Microbes Infect, 1 (14): 1163-1168, 1999.